
Eversana: Advancing Life Sciences Services Globally
EVERSANA stands as a leading independent provider of global commercialization services to the life sciences industry, serving over 650 organizations worldwide since 2018. Headquartered in Chicago, Illinois, this rapidly growing company employs between 5,001-10,000 professionals across 29+ international locations, making it a significant player in pharmaceutical and biotechnology sectors. The company's name reflects its mission-"Sana" meaning healthy in Latin-embodying EVERSANA's commitment to advancing life sciences services toward a healthier world.
Global Impact and Integrated Solutions
EVERSANA's integrated solutions span all stages of the product lifecycle, from innovative startups to established pharmaceutical companies, delivering sustainable value for patients, prescribers, channel partners, and payers. With strategic offices across North America, Europe, and Asia-Pacific-including Chicago, New York, Boston, Toronto, London, Berlin, Shanghai, Tokyo, and Mumbai-employees collaborate on global projects that directly impact healthcare outcomes and bring life-changing treatments to patients faster.
Purpose Driven Culture of Excellence
Certified as a Great Place to Work across the globe, EVERSANA fosters a dynamic, patient-minded environment where innovation meets healthcare impact. The company's core values emphasize client delight, taking action, growing talent, winning together, transparent communication, embracing diversity, and continuous innovation. This collaborative culture encourages professional development and meaningful contributions to healthcare transformation.
Comprehensive Career Benefits
- Health & Wellness: Medical, dental, vision coverage with Health Savings Account and company contributions
- Financial Security: Matching 401(k) plans and flexible spending options
- Time Off: Up to 18 days accrued paid time off plus 10 paid company holidays
- Professional Support: Tuition reimbursement, employee assistance programs, and work-life balance resources
- Work Environment: Temperature-controlled facilities and collaborative spaces designed for productivity
- Career Paths: Diverse opportunities in regulatory affairs, clinical research, market access, and commercial strategy
Why Join Eversana
For healthcare professionals seeking meaningful impact, EVERSANA represents an opportunity to join a forward-thinking organization that combines deep industry expertise with genuine commitment to improving global health outcomes. Whether you're advancing your career in life sciences commercialization or seeking a workplace that values innovation and patient impact, EVERSANA offers the platform, resources, and culture to make a difference.
Mission
A Vision to Advance Life Sciences Services
"Sana" is latin for healthy. So naturally, when service leaders - spanning the patient experience to global channel distribution - combined into one powerful platform, we became EVERSANA.
Together, we will ever evolve and always advance life sciences services toward a healthier world.
Frequently Asked Questions
Jobs for EVERSANA in United States
EVERSANA02298 Boston, MA
EVERSANA66213 Overland Park, KS
EVERSANA19117 Philadelphia, PA
EVERSANA28245 Charlotte, NC
EVERSANA60290 Chicago, IL
EVERSANA66213 Overland Park, KS
EVERSANA31297 Macon, GA
EVERSANA31441 Savannah, GA
EVERSANAMiddlesex County, NJ

Description
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE® (lamotrigine) Oral Suspension
Novel therapy for epilepsy and bipolar disorders received FDA approval in September CHICAGO, Oct. 23, 2025 /PRNewswire/ -- OWP Pharmaceuticals, a privately held, commercial-stage neuroscience specialty pharmaceutical company, today announced that EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, will provide U.S. commercialization services for the launch of SUBVENITE(R) (lamotrigine) oral suspension, the company's novel treatment for epilepsy...
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated Cutaneous T-cell Lymphoma therapy CRANFORD, N.J., Oct. 16, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced it has finalized an exclusive agreement with EVERSANA(R), a leading provider of global commercialization services, to...
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology
CHICAGO, Aug. 4, 2025 /PRNewswire/ -- EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built on Google Cloud technology. The AI Agency, actively deployed and validated for multiple pharmaceutical brands, is 80% AI-powered and automated, reducing marketing costs and rapidly accelerating traditional agency operations. "This...
EVERSANA Unveils EVERSANA ORCHESTRATE PV, An AI-Propelled Solution to Shape the Future of Pharmacovigilance
Expert-led AI multi-platform solution to streamline drug safety workflows with unmatched speed, accuracy and quality CHICAGO, July 17, 2025 /PRNewswire/ -- EVERSANA, a leading provider of global commercial services to the life sciences industry, today announced a new milestone to transform pharmaceutical operations with the launch of EVERSANA ORCHESTRATE PV. The unified, AI-propelled solution accelerates critical pharmacovigilance workflows, including literature monitoring and aggregate...
EVERSANA Announces Enterprise Advancement to 'Pharmatize AI" With the Launch of the EVERSANA AI Accelerator
CHICAGO, July 15, 2025 /PRNewswire/ -- EVERSANA(R), a leading provider of commercialization services to the global life sciences industry, today launched the EVERSANA AI Accelerator, a dedicated center of excellence (COE) focused on the transformation of life sciences commercialization through the power of AI. Under the leadership of Faruk Capan, EVERSANA's Chief Innovation Officer, the EVERSANA AI Accelerator will reimagine every stage of life sciences commercialization through cutting-edge...

Lilly

Pfizer

Eli Lilly and Company

Planet Pharma

CVS Health

Inizio Engage

Discover International

Jazz Pharmaceuticals

Meet Life Sciences

Medasource
